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Introduction
Tuberous sclerosis complex (TSC) is an autosomal dominant 
disorder that affects about 1:6,000 individuals. About two-thirds of 
TSC cases are sporadic, representing spontaneous mutations, while 
one-third are inherited [1]. It is characterized by the development 
of distinctive tumors termed hamartomas in multiple organ systems 
such as brain, retina, skin, heart, lungs, and kidneys [2]. TSC has been 
associated with mutations in either the TSC1 on chromosome 16p13.3 
or TSC2 on chromosome 9q34, which encode hamartin and tuberin, 
respectively. The hamartin/tuberin complex formation is responsible 
for the signaling pathway that regulates a key inhibitor of cell growth 
and metabolism known as mammalian target of rapamycin complex 1 
(mTORC1) [3].
TSC has high variability in clinical presentation and findings. 
Diagnosis of TSC is based on the presence of at least two major clinical 
features, or one major and two minor clinical features [4]. Although 
patients may present with early manifestations of seizures, intellectual 
disability, and skin abnormalities, fewer than 30% have all three and 
6% have none [2]. Previous studies have revealed that patients with 
subtle TSC findings remain either without diagnosis or do not present 
symptoms until later in life (i.e., TSC identified in a parent after an 
affected child was diagnosed).
We are reporting a familial case of TSC with a novel TSC1 
mutation in both affected individuals presenting with mild clinical 
manifestations.
Case Presentation 
A 21-year-old Hispanic female presented with history of epilepsy, 
with seizure onset at age 6. Her seizures are well controlled with 
medication. Her physical examination revealed a fibrous cephalic 
plaque (3.5 cm) and neurological examination was normal. On 
ophthalmic examination, small hamartomatous lesions about 200 to 
300 microns were found. Baseline EEG showed right fronto-temporal 
intermittent discharge activity. A non-contrast brain CT depicted a 
single subependymal nodule (Figure 1A) and brain MRI demonstrated 
a subcortical tuber with associated radial migration line (Figure 1B). 
Renal ultrasound and echocardiogram results were normal and no 
overt pulmonary signs or symptoms (Figure 1C).
Her mother is 51 years old with long-standing history of epilepsy 
controlled with medication. On dermatological examination, there 
were inflamed pedunculated papules on the neck, trunk, and axillae 
consistent with soft fibromas. Multiple cherry angiomas and benign 
nevi were present on the trunk in addition to a hypomelanotic macule 
in the axilla (Figure 1F). Ophthalmic examination showed a few small 
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Abstract
Introduction: Tuberous sclerosis complex (TSC) is a genetic disorder that can arise from sporadic or inherited 
mutations in TSC1 or TSC2 genes. It is characterized by tumors in multiple organs that result in broad clinical 
manifestations, usually affecting the central nervous system. Diagnosis is based upon clinical criteria that require 
careful clinical examination along with imaging and the availability of genetic testing to assess gene mutations linked 
to this disorder. We present a familial case of tuberous sclerosis complex with multiple subtle clinical manifestations 
and novel TSC1 mutation that were diagnosed in adulthood. This report adds to the growing literature on TSC1 gene 
by correlating specific nucleotide substitutions with possible secondary clinical manifestations. 
Case presentation: A 21 year-old Hispanic female presented with history of epilepsy onset in early childhood. 
Upon clinical examination and imaging testing, she was found to have lesions on her scalp, eyes and brain. Her 
mother is 51 years old with long-standing history of epilepsy with multiple lesions on skin, eyes, and similar findings 
in brain imaging to daughter. No additional family history was obtained suggestive of tuberous sclerosis complex. 
Conclusion: Milder forms of tuberous sclerosis complex can remain undiagnosed until adolescence and 
adulthood, which may lead to treatment delay and complications due to the lack of regular follow-up care. In this 
case report, both individuals’ presenting symptom was epilepsy and later other clinical findings were linked to the 
disorder. Additionally, a novel DNA sequence variant was detected, which expands our knowledge of known TSC1 
gene mutations. Although these genetic test results cannot be used alone to make a definite diagnosis, they suggest 
an association to TSC given the clinical manifestations and family history.
Novel TSC1 Gene Mutation in a Familial Case of Tuberous Sclerosis 
Complex: A Case Report
Alberto Pinzon-Ardila1,2*, Claudia Vallin2, Kevin Abrams1 and Ian Miller3
1Neuroscience Center, Baptist Health South Florida, 8900 N Kendall Dr, Miami, FL, USA 
2The Neurology Group. 9090 SW 87 Ct. Suite 200, Miami, FL, USA 
3Brain Institute, Nicklaus Children’s Hospital. 3100 SW 62nd Ave. Miami, FL, USA 
Citation: Pinzon-Ardila A, Vallin C, Abrams K, Miller I (2015) Novel TSC1 Gene Mutation in a Familial Case of Tuberous Sclerosis Complex: A Case 
Report. J Epilepsy 1: 102. doi:10.4172/2472-0895.1000102
Page 2 of 2
Volume 1 • Issue 1 • 1000102
J Epilepsy 
ISSN: 2472-0895 ELJ, an open access journal 
lesions consistent with retinal hamartomas. Brain MRI demonstrated 
a single subependymal nodule, subcortical tubers (Figure 1D), and 
radiation migration lines. Renal ultrasound, echocardiogram, and 
EEG results were normal and no overt pulmonary signs or symptoms 
(Figure 1E).
Genetic testing was conducted by Athena Diagnostics, Inc. TSC1 
and TSC2 genes were analyzed for deletions by using Multiplex 
Ligation-mediated Probe Amplification (MLPA) of genomic DNA. 
DNA sequence analysis was performed by PCR amplification of 
purified genomic DNA, followed by automated DNA sequencing of 
the coding region and the 10 bases of intronic DNA surrounding each 
exon containing the highly conserved exon-intron splice junctions. 
This test detected a DNA sequence variant TSC1 IVS18-6 G>A that 
might interfere with normal splicing in both mother and daughter.
Discussion
TSC is characterized by multisystem involvement that results in a 
wide range of manifestations. Neurologic symptoms are common in 
individuals diagnosed with TSC, as epilepsy occurs in 80-90%, cognitive 
impairment in 50%, and neurobehavioral disorders in >60% of cases 
[5]. However, milder forms of the disorder may lead to diagnosis 
during adolescence and adulthood when more evident manifestations 
are present. 
We describe a mother and daughter with no overt cognitive 
changes and no other family history (neither had siblings) suggestive 
of TSC. The presenting symptom in both individuals was epilepsy 
and other clinical manifestations were later identified as part of TSC. 
They both fulfill definite diagnostic criteria as per the most recent 
diagnostic criteria [4]. The mother has subependymal nodules and 
cortical dysplasia as major features in addition to suspected retinal 
hamartomas and some dermatological findings, and the daughter has 
subependymal nodules, cortical dysplasia, fibrous plaque on scalp, and 
small retinal hamartomas. 
Previous studies have reported that approximately 10-30% of all 
TSC cases are caused by TSC1 mutations [6]. TSC1 mutations are 
associated with a less severe phenotype as compared to TSC2 gene [7]. 
Genetic testing in mother and daughter indicated a single nucleotide 
substitution of A-to-G that is likely pathogenic in TSC1 gene not 
previously described in the literature. These findings along with the 
clinical manifestations suggest this is a novel TSC-causing mutation. 
Conclusion
This report describes a novel TSC1 mutation found in a mother and 
daughter with history of epilepsy and clinical criteria of TSC. Although 
it is not certain that the genetic test findings correlate with TSC, these 
patients’ clinical manifestations and family history are suggestive of its 
association. This novel DNA sequence variant expands the spectrum 
of known TSC1 gene mutations. It supports the growing literature 
that familial cases with TSC1 mutations might have milder clinical 
manifestations. Misdiagnosis of these individuals can be avoided with 
careful clinical examination and genetic testing to be able to provide 
prompt treatment and management. 
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Figure 1: Daughter and mother’s brain imaging and dermatological findings. 
(A) Non-contrast brain CT of daughter: single calcified subependymal 
nodule along the body left lateral ventricle. (B) Brain MRI-Axial FLAIR image 
of daughter: small right parietal subcortical tuber with associated radial 
migration line extending to the right lateral ventricle. (C) 3.5 cm fibrous 
cephalic plaque noted on daughter. (D) Brain MRI-Axial FLAIR image 
of mother: single subependymal nodule along the body of the left lateral 
ventricle. (E) Brain MRI-Coronal FLAIR image of mother: subcortical tuber 
along the left middle frontal gyrus. (F) Single hypomelanotic macule in the 
axilla on mother.
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